Global and United States Viral Molecular Diagnostics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Viral Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Hepatitis B Virus (HBV)
  • 1.2.3 Hepatitis C Virus (HCV)
  • 1.2.4 Human Immunodeficiency Virus (HIV)
  • 1.2.5 Human Papillomavirus (HPV)
• 1.3 Market by Application
  • 1.3.1 Global Viral Molecular Diagnostics Market Share by Application: 2020 VS 2026
  • 1.3.2 Hospitals
  • 1.3.3 Academics Institutions
  • 1.3.4 Laboratories
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Viral Molecular Diagnostics Market Perspective (2015-2026)
• 2.2 Global Viral Molecular Diagnostics Growth Trends by Regions
  • 2.2.1 Viral Molecular Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Viral Molecular Diagnostics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Viral Molecular Diagnostics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Viral Molecular Diagnostics Players by Market Size
  • 3.1.1 Global Top Viral Molecular Diagnostics Players by Revenue (2015-2020)
  • 3.1.2 Global Viral Molecular Diagnostics Revenue Market Share by Players (2015-2020)
• 3.2 Global Viral Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Viral Molecular Diagnostics Revenue
• 3.4 Global Viral Molecular Diagnostics Market Concentration Ratio
  • 3.4.1 Global Viral Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Viral Molecular Diagnostics Revenue in 2019
• 3.5 Key Players Viral Molecular Diagnostics Area Served
• 3.6 Key Players Viral Molecular Diagnostics Product Solution and Service
• 3.7 Date of Enter into Viral Molecular Diagnostics Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Viral Molecular Diagnostics Breakdown Data by Type (2015-2026)

• 4.1 Global Viral Molecular Diagnostics Historic Market Size by Type (2015-2020)
• 4.2 Global Viral Molecular Diagnostics Forecasted Market Size by Type (2021-2026)

5 Viral Molecular Diagnostics Breakdown Data by Application (2015-2026)

• 5.1 Global Viral Molecular Diagnostics Historic Market Size by Application (2015-2020)
• 5.2 Global Viral Molecular Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Viral Molecular Diagnostics Market Size (2015-2026)
• 6.2 North America Viral Molecular Diagnostics Market Size by Type (2015-2020)
• 6.3 North America Viral Molecular Diagnostics Market Size by Application (2015-2020)
• 6.4 North America Viral Molecular Diagnostics Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Viral Molecular Diagnostics Market Size (2015-2026)
• 7.2 Europe Viral Molecular Diagnostics Market Size by Type (2015-2020)
• 7.3 Europe Viral Molecular Diagnostics Market Size by Application (2015-2020)
• 7.4 Europe Viral Molecular Diagnostics Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Viral Molecular Diagnostics Market Size (2015-2026)
• 8.2 China Viral Molecular Diagnostics Market Size by Type (2015-2020)
• 8.3 China Viral Molecular Diagnostics Market Size by Application (2015-2020)
• 8.4 China Viral Molecular Diagnostics Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Viral Molecular Diagnostics Market Size (2015-2026)
• 9.2 Japan Viral Molecular Diagnostics Market Size by Type (2015-2020)
• 9.3 Japan Viral Molecular Diagnostics Market Size by Application (2015-2020)
• 9.4 Japan Viral Molecular Diagnostics Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Viral Molecular Diagnostics Market Size (2015-2026)
• 10.2 Southeast Asia Viral Molecular Diagnostics Market Size by Type (2015-2020)
• 10.3 Southeast Asia Viral Molecular Diagnostics Market Size by Application (2015-2020)
• 10.4 Southeast Asia Viral Molecular Diagnostics Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Abbott Laboraories
  • 11.1.1 Abbott Laboraories Company Details
  • 11.1.2 Abbott Laboraories Business Overview
  • 11.1.3 Abbott Laboraories Viral Molecular Diagnostics Introduction
  • 11.1.4 Abbott Laboraories Revenue in Viral Molecular Diagnostics Business (2015-2020))
  • 11.1.5 Abbott Laboraories Recent Development
• 11.2 Bio-Rad Laboratories
  • 11.2.1 Bio-Rad Laboratories Company Details
  • 11.2.2 Bio-Rad Laboratories Business Overview
  • 11.2.3 Bio-Rad Laboratories Viral Molecular Diagnostics Introduction
  • 11.2.4 Bio-Rad Laboratories Revenue in Viral Molecular Diagnostics Business (2015-2020)
  • 11.2.5 Bio-Rad Laboratories Recent Development
• 11.3 Becton, Dickinson
  • 11.3.1 Becton, Dickinson Company Details
  • 11.3.2 Becton, Dickinson Business Overview
  • 11.3.3 Becton, Dickinson Viral Molecular Diagnostics Introduction
  • 11.3.4 Becton, Dickinson Revenue in Viral Molecular Diagnostics Business (2015-2020)
  • 11.3.5 Becton, Dickinson Recent Development
• 11.4 Roche
  • 11.4.1 Roche Company Details
  • 11.4.2 Roche Business Overview
  • 11.4.3 Roche Viral Molecular Diagnostics Introduction
  • 11.4.4 Roche Revenue in Viral Molecular Diagnostics Business (2015-2020)
  • 11.4.5 Roche Recent Development
• 11.5 Gen-Probe
  • 11.5.1 Gen-Probe Company Details
  • 11.5.2 Gen-Probe Business Overview
  • 11.5.3 Gen-Probe Viral Molecular Diagnostics Introduction
  • 11.5.4 Gen-Probe Revenue in Viral Molecular Diagnostics Business (2015-2020)
  • 11.5.5 Gen-Probe Recent Development
• 11.6 Qiagen
  • 11.6.1 Qiagen Company Details
  • 11.6.2 Qiagen Business Overview
  • 11.6.3 Qiagen Viral Molecular Diagnostics Introduction
  • 11.6.4 Qiagen Revenue in Viral Molecular Diagnostics Business (2015-2020)
  • 11.6.5 Qiagen Recent Development
• 11.7 Olympus
  • 11.7.1 Olympus Company Details
  • 11.7.2 Olympus Business Overview
  • 11.7.3 Olympus Viral Molecular Diagnostics Introduction
  • 11.7.4 Olympus Revenue in Viral Molecular Diagnostics Business (2015-2020)
  • 11.7.5 Olympus Recent Development
• 11.8 Thermo Fisher Scientific
  • 11.8.1 Thermo Fisher Scientific Company Details
  • 11.8.2 Thermo Fisher Scientific Business Overview
  • 11.8.3 Thermo Fisher Scientific Viral Molecular Diagnostics Introduction
  • 11.8.4 Thermo Fisher Scientific Revenue in Viral Molecular Diagnostics Business (2015-2020)
  • 11.8.5 Thermo Fisher Scientific Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer